Page last updated: 2024-10-28

guaifenesin and Bowel Diseases, Inflammatory

guaifenesin has been researched along with Bowel Diseases, Inflammatory in 45 studies

Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.

Research Excerpts

ExcerptRelevanceReference
"Arctigenin was demonstrated to promote the mucus secretion and maintain the integrity of mucus barrier, which might be achieved by an increase in the number of goblet cells via inhibiting apoptosis."5.72Phytoestrogen arctigenin preserves the mucus barrier in inflammatory bowel diseases by inhibiting goblet cell apoptosis via the ERβ/TRIM21/PHB1 pathway. ( Dai, Y; Fang, YL; Lv, CJ; Qiao, SM; Tao, Y; Wei, ZF; Xia, YF; Yue, MF; Yun, XM, 2022)
" Nonetheless, these drugs suffer from severe side effects or poor efficacy due to low bioavailability in the inflamed region of the intestinal tract."2.82Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems. ( Bouchemal, K; Hadji, H, 2022)
"Arctigenin was demonstrated to promote the mucus secretion and maintain the integrity of mucus barrier, which might be achieved by an increase in the number of goblet cells via inhibiting apoptosis."1.72Phytoestrogen arctigenin preserves the mucus barrier in inflammatory bowel diseases by inhibiting goblet cell apoptosis via the ERβ/TRIM21/PHB1 pathway. ( Dai, Y; Fang, YL; Lv, CJ; Qiao, SM; Tao, Y; Wei, ZF; Xia, YF; Yue, MF; Yun, XM, 2022)

Research

Studies (45)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (8.89)18.2507
2000's6 (13.33)29.6817
2010's22 (48.89)24.3611
2020's13 (28.89)2.80

Authors

AuthorsStudies
Chen, Z2
Shen, X1
Zhou, Q1
Zhan, Q1
Xu, X1
Chen, Q1
An, F1
Sun, J1
Fernández-Tomé, S1
Ortega Moreno, L1
Chaparro, M1
Gisbert, JP1
Reyes Nicolás, V1
Allaire, JM2
Alfonso, AB1
Pupo Gómez, D1
Pomerleau, V1
Giroux, V1
Boudreau, F1
Perreault, N1
Stiegeler, S1
Mercurio, K1
Iancu, MA1
Corr, SC1
Hadji, H1
Bouchemal, K1
Yao, Y1
Kim, G1
Shafer, S1
Kubo, S1
Ji, Y1
Luo, J1
Yang, W1
Perner, SP1
Kanellopoulou, C1
Park, AY1
Jiang, P1
Li, J1
Baris, S1
Aydiner, EK1
Ertem, D1
Mulder, DJ1
Warner, N1
Griffiths, AM1
Topf-Olivestone, C1
Kori, M1
Werner, L1
Ouahed, J1
Field, M1
Liu, C1
Schwarz, B1
Bosio, CM1
Ganesan, S1
Song, J1
Urlaub, H1
Oellerich, T1
Malaker, SA1
Zheng, L1
Bertozzi, CR1
Zhang, Y1
Matthews, H1
Montgomery, W1
Shih, HY1
Jiang, J1
Jones, M1
Baras, A1
Shuldiner, A1
Gonzaga-Jauregui, C1
Snapper, SB1
Muise, AM1
Shouval, DS1
Ozen, A1
Pan, KT1
Wu, C1
Lenardo, MJ1
Nooredinvand, HA1
Poullis, A2
Tao, Y1
Qiao, SM1
Lv, CJ1
Yun, XM1
Yue, MF1
Fang, YL1
Wei, ZF1
Dai, Y1
Xia, YF1
Wu, Z1
Liu, X1
Huang, S1
Li, T1
Zhang, X2
Pang, J1
Zhao, J1
Chen, L1
Zhang, B1
Wang, J1
Han, D1
Song, C1
Chai, Z1
Chen, S1
Zhang, H1
Zhou, Y1
Volk, JK1
Nyström, EEL1
van der Post, S1
Abad, BM1
Schroeder, BO1
Johansson, Å1
Svensson, F1
Jäverfelt, S1
Johansson, MEV1
Hansson, GC1
Birchenough, GMH1
Paone, P1
Cani, PD1
Placet, M1
Molle, CM1
Arguin, G1
Geha, S1
Gendron, FP1
Al-Shaibi, AA1
Abdel-Motal, UM1
Hubrack, SZ1
Bullock, AN1
Al-Marri, AA1
Agrebi, N1
Al-Subaiey, AA1
Ibrahim, NA1
Charles, AK1
Elawad, M1
Uhlig, HH1
Lo, B1
Capaldo, CT1
Powell, DN1
Kalman, D1
Hecht, AL1
Casterline, BW1
Choi, VM1
Bubeck Wardenburg, J1
Mizoguchi, A1
Yano, A1
Himuro, H1
Ezaki, Y1
Sadanaga, T1
Mizoguchi, E1
Morampudi, V1
Crowley, SM1
Stahl, M1
Yu, H1
Bhullar, K1
Knodler, LA1
Bressler, B1
Jacobson, K1
Vallance, BA1
Wu, HM1
Wei, J1
Wang, K1
Qi, Y1
Wang, FY1
Date, AA1
Halpert, G1
Babu, T1
Ortiz, J1
Kanvinde, P1
Dimitrion, P1
Narayan, J1
Zierden, H1
Betageri, K1
Musmanno, O1
Wiegand, H1
Huang, X1
Gumber, S1
Hanes, J1
Ensign, LM1
Ring, C1
Klopfleisch, R1
Dahlke, K1
Basic, M1
Bleich, A1
Blaut, M1
Chuang, LS1
Morrison, J1
Hsu, NY1
Labrias, PR1
Nayar, S1
Chen, E1
Villaverde, N1
Facey, JA1
Boschetti, G1
Giri, M1
Castillo-Martin, M1
Thin, TH1
Sharma, Y1
Chu, J1
Cho, JH1
Hardy, H1
Harris, J1
Lyon, E1
Beal, J1
Foey, AD1
Klag, T1
Stange, EF1
Wehkamp, J1
Huang, Z1
Wang, Z1
Long, S1
Jiang, H2
Chen, J1
Zhang, J1
Dong, L1
Theodoratou, E1
Campbell, H1
Ventham, NT1
Kolarich, D1
Pučić-Baković, M1
Zoldoš, V1
Fernandes, D1
Pemberton, IK1
Rudan, I1
Kennedy, NA1
Wuhrer, M1
Nimmo, E1
Annese, V1
McGovern, DP1
Satsangi, J1
Lauc, G1
Johansson, ME1
Pookhao, N1
Sohn, MB1
Li, Q1
Jenkins, I1
Du, R1
An, L1
Goll, R1
van Beelen Granlund, A1
Gouyer, V1
Dubuquoy, L1
Robbe-Masselot, C1
Neut, C1
Singer, E1
Plet, S1
Geboes, K1
Desreumaux, P1
Gottrand, F1
Desseyn, JL1
Loktionov, A1
Chhaya, V1
Bandaletova, T1
Glade, MJ1
Meguid, MM1
Qin, X2
Corazziari, ES1
Fyderek, K1
Strus, M1
Kowalska-Duplaga, K1
Gosiewski, T1
Wedrychowicz, A1
Jedynak-Wasowicz, U1
Sładek, M1
Pieczarkowski, S1
Adamski, P1
Kochan, P1
Heczko, PB1
Bachmann, O1
Seidler, U1
Cario, E1
Castagliuolo, I1
Galeazzi, F1
Ferrari, S1
Elli, M1
Brun, P1
Cavaggioni, A1
Tormen, D1
Sturniolo, GC1
Morelli, L1
Palù, G1
Zhang, L1
Mitchell, H1
Fargeas, MJ1
Theodorou, V1
More, J1
Wal, JM1
Fioramonti, J1
Bueno, L1
Ryder, SD2
Parker, N2
Ecclestone, D1
Haqqani, MT1
Rhodes, JM2
Raouf, AH1
Walker, RJ1
Schultsz, C1
Van Den Berg, FM1
Ten Kate, FW1
Tytgat, GN1
Dankert, J1
Halm, DR1
Halm, ST1

Reviews

17 reviews available for guaifenesin and Bowel Diseases, Inflammatory

ArticleYear
Gut Microbiota and Dietary Factors as Modulators of the Mucus Layer in Inflammatory Bowel Disease.
    International journal of molecular sciences, 2021, Sep-23, Volume: 22, Issue:19

    Topics: Animals; Diet; Gastrointestinal Microbiome; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa;

2021
The Impact of MicroRNAs during Inflammatory Bowel Disease: Effects on the Mucus Layer and Intercellular Junctions for Gut Permeability.
    Cells, 2021, 11-30, Volume: 10, Issue:12

    Topics: Animals; Gastrointestinal Tract; Humans; Inflammatory Bowel Diseases; Intercellular Junctions; Micro

2021
Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems.
    Advanced drug delivery reviews, 2022, Volume: 181

    Topics: Administration, Oral; Drug Delivery Systems; Gastrointestinal Agents; Humans; Hydrogen-Ion Concentra

2022
Emerging role of colorectal mucus in gastroenterology diagnostics.
    World journal of gastroenterology, 2022, Mar-28, Volume: 28, Issue:12

    Topics: Biomarkers; Colonoscopy; Colorectal Neoplasms; Feces; Gastroenterology; Humans; Inflammatory Bowel D

2022
Intestinal mucus components and secretion mechanisms: what we do and do not know.
    Experimental & molecular medicine, 2023, Volume: 55, Issue:4

    Topics: Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Intestines; Mucus

2023
Mucus barrier, mucins and gut microbiota: the expected slimy partners?
    Gut, 2020, Volume: 69, Issue:12

    Topics: Diet; Gastrointestinal Microbiome; Gastrointestinal Tract; Host Microbial Interactions; Humans; Infl

2020
Layered defense: how mucus and tight junctions seal the intestinal barrier.
    Journal of molecular medicine (Berlin, Germany), 2017, Volume: 95, Issue:9

    Topics: Animals; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Mucins; Mucus; Permeability; Tight

2017
Clinical importance of IL-22 cascade in IBD.
    Journal of gastroenterology, 2018, Volume: 53, Issue:4

    Topics: Gastrointestinal Agents; Genetic Predisposition to Disease; Humans; Immunity, Mucosal; Inflammatory

2018
Frontline defenders: goblet cell mediators dictate host-microbe interactions in the intestinal tract during health and disease.
    American journal of physiology. Gastrointestinal and liver physiology, 2018, 03-01, Volume: 314, Issue:3

    Topics: Animals; Bacteria; Bacterial Infections; Gastrointestinal Microbiome; Goblet Cells; Homeostasis; Hos

2018
Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology.
    Nutrients, 2013, May-29, Volume: 5, Issue:6

    Topics: Animals; Antimicrobial Cationic Peptides; Bacteria; Colorectal Neoplasms; Dietary Fiber; Epithelial

2013
Defective antibacterial barrier in inflammatory bowel disease.
    Digestive diseases (Basel, Switzerland), 2013, Volume: 31, Issue:3-4

    Topics: alpha-Defensins; Animals; Antimicrobial Cationic Peptides; beta-Defensins; Humans; Inflammatory Bowe

2013
The role of glycosylation in IBD.
    Nature reviews. Gastroenterology & hepatology, 2014, Volume: 11, Issue:10

    Topics: Animals; Galactose; Glycosylation; Humans; Immunoglobulin G; Inflammatory Bowel Diseases; Intestinal

2014
Mucus layers in inflammatory bowel disease.
    Inflammatory bowel diseases, 2014, Volume: 20, Issue:11

    Topics: Animals; Humans; Inflammatory Bowel Diseases; Mucous Membrane; Mucus

2014
Intestinal barrier homeostasis in inflammatory bowel disease.
    Scandinavian journal of gastroenterology, 2015, Volume: 50, Issue:1

    Topics: Biomarkers; Enteroendocrine Cells; Homeostasis; Humans; Inflammatory Bowel Diseases; Intestinal Muco

2015
News from the end of the gut--how the highly segmental pattern of colonic HCO₃⁻ transport relates to absorptive function and mucosal integrity.
    Biological & pharmaceutical bulletin, 2011, Volume: 34, Issue:6

    Topics: Animals; Bicarbonates; Chloride-Bicarbonate Antiporters; Colon; Fatty Acids, Volatile; Humans; Infla

2011
Commensal-innate immune miscommunication in IBD pathogenesis.
    Digestive diseases (Basel, Switzerland), 2012, Volume: 30, Issue:4

    Topics: Bacteria; Cell Transformation, Neoplastic; Epithelium; Humans; Immunity; Inflammatory Bowel Diseases

2012
The roles of mucus-associated bacteria in inflammatory bowel disease.
    Drugs of today (Barcelona, Spain : 1998), 2006, Volume: 42, Issue:9

    Topics: Adult; Animals; Disease Models, Animal; Helicobacter; Humans; Inflammatory Bowel Diseases; Mucus

2006

Other Studies

28 other studies available for guaifenesin and Bowel Diseases, Inflammatory

ArticleYear
Dietary xylo-oligosaccharide ameliorates colonic mucus microbiota penetration with restored autophagy in interleukin-10 gene-deficient mice.
    JPEN. Journal of parenteral and enteral nutrition, 2022, Volume: 46, Issue:5

    Topics: Animals; Autophagy; Colitis; Inflammatory Bowel Diseases; Interleukin-10; Male; Mice; Microbiota; Mu

2022
Altered Mucus Barrier Integrity and Increased Susceptibility to Colitis in Mice upon Loss of Telocyte Bone Morphogenetic Protein Signalling.
    Cells, 2021, 10-29, Volume: 10, Issue:11

    Topics: Animals; Bone Morphogenetic Protein Receptors, Type I; Bone Morphogenetic Proteins; Colitis; Colon;

2021
Mucus sialylation determines intestinal host-commensal homeostasis.
    Cell, 2022, 03-31, Volume: 185, Issue:7

    Topics: Animals; Gastrointestinal Microbiome; Homeostasis; Humans; Inflammatory Bowel Diseases; Intestinal M

2022
Phytoestrogen arctigenin preserves the mucus barrier in inflammatory bowel diseases by inhibiting goblet cell apoptosis via the ERβ/TRIM21/PHB1 pathway.
    Phytotherapy research : PTR, 2022, Volume: 36, Issue:8

    Topics: Animals; Apoptosis; Colitis; Estrogen Receptor beta; Furans; Goblet Cells; Inflammatory Bowel Diseas

2022
Milk Fat Globule Membrane Attenuates Acute Colitis and Secondary Liver Injury by Improving the Mucus Barrier and Regulating the Gut Microbiota.
    Frontiers in immunology, 2022, Volume: 13

    Topics: Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Glycolipids;

2022
The Nlrp6 inflammasome is not required for baseline colonic inner mucus layer formation or function.
    The Journal of experimental medicine, 2019, 11-04, Volume: 216, Issue:11

    Topics: Animals; Colon; Gastrointestinal Microbiome; Goblet Cells; Inflammasomes; Inflammatory Bowel Disease

2019
The expression of P2Y
    The FEBS journal, 2021, Volume: 288, Issue:18

    Topics: Animals; Colitis; Dextran Sulfate; Gene Expression Regulation; Goblet Cells; Humans; Inflammatory Bo

2021
Human AGR2 Deficiency Causes Mucus Barrier Dysfunction and Infantile Inflammatory Bowel Disease.
    Cellular and molecular gastroenterology and hepatology, 2021, Volume: 12, Issue:5

    Topics: Amino Acid Sequence; Animals; Biomarkers; Disease Models, Animal; Disease Susceptibility; Endoplasmi

2021
A Two-Component System Regulates Bacteroides fragilis Toxin to Maintain Intestinal Homeostasis and Prevent Lethal Disease.
    Cell host & microbe, 2017, Oct-11, Volume: 22, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Bacteroides fragilis; Colorect

2017
Mucus protectors: Promising therapeutic strategies for inflammatory bowel disease.
    Medical hypotheses, 2018, Volume: 120

    Topics: Animals; Cytokines; Enzymes; Gastrointestinal Microbiome; Glycoside Hydrolases; Humans; Hydrogen-Ion

2018
Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease.
    Biomaterials, 2018, Volume: 185

    Topics: Animals; Anti-Inflammatory Agents; Budesonide; Colon; Drug Compounding; Drug Delivery Systems; Enema

2018
Akkermansia muciniphila strain ATCC BAA-835 does not promote short-term intestinal inflammation in gnotobiotic interleukin-10-deficient mice.
    Gut microbes, 2019, Volume: 10, Issue:2

    Topics: Animals; Body Weight; Cecum; Disease Models, Animal; Escherichia coli; Gastrointestinal Microbiome;

2019
Zebrafish modeling of intestinal injury, bacterial exposures and medications defines epithelial
    Disease models & mechanisms, 2019, 08-13, Volume: 12, Issue:8

    Topics: Acids; Animals; Autophagy; Bacterial Proteins; Dextran Sulfate; Dinoprostone; Disease Models, Animal

2019
A 3-D artificial colon tissue mimic for the evaluation of nanoparticle-based drug delivery system.
    Molecular pharmaceutics, 2014, Jul-07, Volume: 11, Issue:7

    Topics: Animals; Biomimetics; Caco-2 Cells; Colitis; Colon; Cytokines; Drug Delivery Systems; Drug Evaluatio

2014
A two-stage statistical procedure for feature selection and comparison in functional analysis of metagenomes.
    Bioinformatics (Oxford, England), 2015, Jan-15, Volume: 31, Issue:2

    Topics: Case-Control Studies; Data Interpretation, Statistical; Gastrointestinal Tract; Gene Expression Regu

2015
Delivery of a mucin domain enriched in cysteine residues strengthens the intestinal mucous barrier.
    Scientific reports, 2015, May-14, Volume: 5

    Topics: Animals; Citrobacter rodentium; Cysteine; Epithelial Cells; Escherichia coli; Gastrointestinal Micro

2015
Assessment of cytology and mucin 2 in colorectal mucus collected from patients with inflammatory bowel disease: Results of a pilot trial.
    Journal of gastroenterology and hepatology, 2016, Volume: 31, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Colon; Cytological Techniques; Feasibility S

2016
A glance at … dietary emulsifiers, the human intestinal mucus and microbiome, and dietary fiber.
    Nutrition (Burbank, Los Angeles County, Calif.), 2016, Volume: 32, Issue:5

    Topics: Bacterial Translocation; Dietary Fiber; Emulsifying Agents; Food Additives; Gastrointestinal Microbi

2016
Damage of the Mucus Layer: The Possible Shared Critical Common Cause for Both Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).
    Inflammatory bowel diseases, 2017, Volume: 23, Issue:2

    Topics: Humans; Inflammatory Bowel Diseases; Irritable Bowel Syndrome; Mucus

2017
Intestinal mucus barrier in normal and inflamed colon.
    Journal of pediatric gastroenterology and nutrition, 2009, Volume: 48 Suppl 2

    Topics: Bacteria; Bacterial Physiological Phenomena; Biofilms; Colon; Humans; Inflammatory Bowel Diseases; I

2009
Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease.
    World journal of gastroenterology, 2009, Nov-14, Volume: 15, Issue:42

    Topics: Adolescent; Bacteria; Biopsy; Case-Control Studies; Child; Colonoscopy; Colony Count, Microbial; Fem

2009
Beneficial effect of auto-aggregating Lactobacillus crispatus on experimentally induced colitis in mice.
    FEMS immunology and medical microbiology, 2005, Feb-01, Volume: 43, Issue:2

    Topics: Animals; Bacterial Adhesion; Dextran Sulfate; Disease Models, Animal; Feces; Inflammatory Bowel Dise

2005
Synergic effect of bacterial glycosidases and digestive proteases on mucus degradation and the reduced risk of inflammatory bowel disease-like gut damage in both germ-free and poor hygiene conditions.
    Inflammatory bowel diseases, 2008, Volume: 14, Issue:1

    Topics: Bacterial Proteins; Glycoside Hydrolases; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Mu

2008
Boosted systemic immune and local responsiveness after intestinal inflammation in orally sensitized guinea pigs.
    Gastroenterology, 1995, Volume: 109, Issue:1

    Topics: Analysis of Variance; Animals; Cell Membrane Permeability; Colon; Edetic Acid; Guinea Pigs; Histamin

1995
Peanut lectin stimulates proliferation in colonic explants from patients with inflammatory bowel disease and colon polyps.
    Gastroenterology, 1994, Volume: 106, Issue:1

    Topics: Acetylglucosamine; Adolescent; Adult; Aged; Cell Division; Colon; Colonic Polyps; Culture Techniques

1994
Abnormal mucosal glycoprotein synthesis in inflammatory bowel diseases is not related to cigarette smoking.
    Digestion, 1995, Volume: 56, Issue:5

    Topics: Acetylglucosamine; Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Biopsy; Colonos

1995
The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls.
    Gastroenterology, 1999, Volume: 117, Issue:5

    Topics: Bacteria; Biopsy; Colon; Colony Count, Microbial; Humans; Ileum; In Situ Hybridization; Inflammatory

1999
Secretagogue response of goblet cells and columnar cells in human colonic crypts.
    American journal of physiology. Cell physiology, 2000, Volume: 278, Issue:1

    Topics: Adenosine; Biological Transport; Body Fluids; Carbachol; Cell Size; Cholecystokinin; Cholinergic Ago

2000